ebook Munafa Stock Market Course + Intraday & FNO calls  

       

506235 announcements Alembic Ltd. announcements and dividends declared BSE

Alembic Ltd. Complete list of announcements declared & dividend announcements by Alembic Ltd. 506235

Alembic Ltd. 506235 listed on BSE and deals in

Announcements and dividends declared by Alembic Ltd. 506235

Alembic Pharma gets USFDA nod for generic hypertension treatment capsules
Alembic Pharmaceuticals has received USFDA final approval for its generic Diltiazem Hydrochloride extended-release capsules in strengths of 120 mg, 180 mg, and 240 mg to treat hypertension and chronic stable angina. These capsules are therapeutically equiv
Announcement as on 21 October 2024

Alembic Pharma gets USFDA nod for generic drug used to treat schizophrenia
Alembic Pharmaceuticals has received final approval from the USFDA for its generic version of Paliperidone extended-release tablets, used to treat schizophrenia and schizoaffective disorder. The approval covers strengths of 1.5 mg, 3 mg, 6 mg, and 9 mg. Th
Announcement as on 27 September 2024

Alembic Pharma gets USFDA nod for generic product
Alembic Pharmaceuticals has received approval from the USFDA to market Albendazole Tablets USP (200 mg), a generic drug for treating infections caused by worms. The tablets are equivalent to Impax Laboratories' Albenza and are used for conditions like pare
Announcement as on 05 September 2024

Alembic Pharma gets USFDA nod for generic drug
Alembic Pharmaceuticals has been granted final approval from the USFDA for its generic Betamethasone Valerate Foam, intended to treat moderate-to-severe psoriasis of the scalp. This medication is equivalent to Luxiq Foam by Norvium Bioscience. Alembic’s
Announcement as on 26 August 2024

Alembic Pharmaceuticals receives USFDA approval for Betamethasone Valerate Foam
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Betamethasone Valerate Foam, 0.12%. The approved ANDA is therapeutically equivalent to the reference listed d
Announcement as on 24 August 2024

Announcements by Alembic Ltd. first page | Next page | Prev page |

506235 Alembic Ltd. current price & indicator signals

Moving Averages for Alembic Ltd.

  • 5Day Average: 98.95
  • 12Day Average: 100.32
  • 20Day Average: 99.9
  • 50Day Average: 100.23
  • 100Day Average: 103.95
  • 150Day Average: 107.09
  • 200Day Average: 105.04

506235 Indicators & signals

Indicator MACD (12,26,9)

99.96, 100.11, -0.2
Indicator MACD is in negative zone

Indicator ADX (14)

8.82, 28.79, 24.12
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 57
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 506235 Alembic Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
12 Fri Dec 2025 101.98 98.99 to 102.25 2.92% 1.16 times
11 Thu Dec 2025 99.09 96.64 to 99.82 1.38% 0.27 times
10 Wed Dec 2025 97.74 97.34 to 99.09 -0.44% 0.39 times
09 Tue Dec 2025 98.17 95.00 to 98.40 0.4% 0.81 times
08 Mon Dec 2025 97.78 97.28 to 101.75 -3.17% 0.73 times
05 Fri Dec 2025 100.98 100.48 to 102.70 -1.66% 0.49 times
04 Thu Dec 2025 102.68 101.34 to 103.20 -0.01% 0.23 times
03 Wed Dec 2025 102.69 102.13 to 106.50 0.1% 2.95 times
02 Tue Dec 2025 102.59 99.13 to 104.56 2.43% 3.31 times
01 Mon Dec 2025 100.16 98.62 to 100.33 0.16% 0.45 times
28 Fri Nov 2025 100.00 99.53 to 100.33 -0.01% 0.37 times
27 Thu Nov 2025 100.01 99.11 to 100.65 0.72% 0.61 times

Videos related to: 506235 announcements Alembic Ltd. announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

506235 announcements Alembic Ltd. announcements and dividends declared BSE

 

Back to top